March, 2025

article thumbnail

Opinion: Herding cats: It’s past time to include pets in disease surveillance

STAT

As veterinarians, flu scientists, and biosecurity experts, we have watched with growing concern the rise in H5N1 avian influenza in cats. Since 2022, more than 100 domesticated cats in the United States have had confirmed infections — some house pets, some barn cats, some feral — with high mortality, although mortality data remain undocumented on federal sites.

363
363
article thumbnail

NHS England to be scrapped with funding 'reinvested into frontline services'

The Pharmacist

NHS England (NHSE) will be scrapped and brought back into the Department of Health and Social Care (DHSC) 'to put an end to the duplication resulting from two organisations doing the same job', the government has said today. Prime Minister Sir Kier Starmer set out major reforms today, which will include the dissolution of NHSE […] The post NHS England to be scrapped with funding 'reinvested into frontline services' appeared first on The Pharmacist.

119
119
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What’s driving pharma’s layoffs in 2025

PharmaVoice

Familiar foes in the industry have claimed a slew of jobs in recent months.

294
294
article thumbnail

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

Express Pharma

What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceutical manufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands. The following trends not only shaped the sector then but also set the stage for the future of pharma manufacturing, both in India and globally.

article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Brexit a key factor in worst UK medicine shortages in four years, report says

The Guardian - Pharmaceutical Industry

Nuffield Trust says supply chains have shifted, with drugs for epilepsy and cystic fibrosis among those now scarce Drug shortages in the UK have risen to their worst level for four years, official figures show, with Brexit considered a key reason so many medications are scarce. Drug companies notified the Department of Health and Social Care (DHSC) about disruptions to supply 1,938 times during last year the highest number since the 1,967 seen in 2021.

112
112

More Trending

article thumbnail

Former CDC director Tom Frieden shares warning for RFK Jr. on measles outbreak

STAT

NEW YORK —   A former top federal health official is publicly warning Robert F. Kennedy Jr. that wavering on vaccines and slashing federal programs during a deadly measles outbreak could unleash the next public health disaster.  “The federal government might pause, but the measles virus doesn’t pause. Bacteria and viruses don’t pause.

Vaccines 362
article thumbnail

Campaign for practice pharmacists to have 10% protected learning time

The Pharmacist

Pharmacists should be given 10% of their hours as protected learning time, the Guild of Healthcare Pharmacists (GHP) has suggested in a new national campaign. Speaking to The Pharmacist, GHP primary care chair Laura Buckley said there was significant variation in pharmacist access to protected learning time in GP practices and primary care networks (PCNs) […] The post Campaign for practice pharmacists to have 10% protected learning time appeared first on The Pharmacist.

119
119
article thumbnail

Psilocybin therapy demonstrates sustained clinical benefit in treatment-resistant depression

European Pharmaceutical Review

New results from a trial investigating a synthetic form of psilocybin, administered with psychological support, showed that it extended the time participants with treatment-resistant depression (TRD) were free from depressive symptoms. A single 25mg dose of COMP360 psilocybin had benefit over smaller 1mg and 10mg doses in the 52-week COMP004 follow-up study to the Phase IIb (COMP001 and COMP003) trials.

98
article thumbnail

Lilly launches Mounjaro (tirzepatide), offers new treatment option for obesity and type 2 diabetes

Express Pharma

Eli Lilly and Company (India) announced the launch of Mounjaro in single-dose vial presentation following the marketing authorisation from the Central Drugs Standard Control Organization (CDSCO). It is a treatment for obesity, overweight, and type 2 diabetes that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.

Diabetes 101
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

How pharma could feel the pain of a recession

PharmaVoice

Pharma has long been considered “recession proof,” but an economic downturn could still hurt the industry in numerous ways.

232
232
article thumbnail

A closer look at how health care consolidation drives up patient costs, creates barriers to care

PhRMA

Half of every dollar spent on medicines goes to entities that don’t make medicine—like pharmacy benefit managers (PBMs) and insurers who are aggressively consolidating their control over health care and hospitals, clinics and for-profit pharmacies in the 340B markup program. As entities in the supply chain that don’t make medicine are increasingly using medicines to subsidize other parts of their business, patients and employers face increasing costs and barriers to accessing c

Hospitals 107
article thumbnail

Opinion: How to protect the American egg supply from avian flu  

STAT

Wholesale egg prices have dropped by more than 40% since late February, a decline that should soon translate into broader savings for consumers at grocery stores. This welcome respite has largely resulted from the lull in significant bird flu outbreaks in recent weeks, perhaps due to seasonal patterns in the virus’s transmission. North American flyways typically remain quiet in February as migratory birds have yet to start their journeys from their winter habitats.

article thumbnail

Pharmacy First IT funding 'not well spent', says pharmacist MP

The Pharmacist

Money to develop IT systems to support the roll-out of Pharmacy First was 'not well spent', pharmacist and MP Sadik Al-Hassan has suggested. The Labour MP for North Somerset was speaking at a roundtable focusing on community pharmacy technology in parliament yesterday when he was asked by The Pharmacist for his views on the IT […] The post Pharmacy First IT funding 'not well spent', says pharmacist MP appeared first on The Pharmacist.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Drug Patent Expirations: Unlocking Strategic Investment Opportunities

Drug Patent Watch

Unlocking Strategic Investment Opportunities in the Pharmaceutical Industry As we navigate the ever-evolving landscape of the pharmaceutical industry, one thing remains constant: the expiration of patents on blockbuster medications. These expirations can have a significant impact on the market, creating opportunities for strategic investment and growth.

article thumbnail

Leadership evolution in India’s pharmaceutical sector in 2025- Driving global growth and innovation

Express Pharma

The Indian pharmaceutical industry is evolving rapidly, leading to the emergence of new leadership roles that address the sector’s dynamic global challenges and opportunities. As the sector adapts to technological advancements, regulatory requirements, and increasing competition, several leadership role trends are emerging. These roles are designed to strengthen the companies’ operational efficiency, expand their market presence, and foster innovation.

article thumbnail

Transforming biopharma’s approach to patient engagement with direct-to-patient programs

PharmaVoice

Consumers want more from biopharma. Next-generation direct-to-patient programs can deliver.

246
246
article thumbnail

Five Things For Pharmacists To Know About Measles in 2025

ID Stewardship

In this article a clinical infectious diseases pharmacist reviews five things for pharmacists to know about measles in 2025. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP – – POST UNDER CONSTRUCTION – – Article posted 8 March 2025 This week on Tuesday night a few text messages came through on WhatsApp chats about how there was a measles case from a high school student here in the Miami area.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Mayo Clinic’s partnership with dairy poses conflict of interest, critics say

STAT

In the world of nutrition research, dairy is neither hero nor villain. It contains important nutrients like protein and calcium. Yet full-fat dairy also contains relatively high levels of saturated fat, which has been linked to increased levels of harmful LDL cholesterol and greater risk of stroke and heart disease. These complexities mean many health providers aim for nuance in how they talk about dairy, avoiding the full-throated endorsements they might give to leafy greens or legumes while di

article thumbnail

Boots Paracetamol batch recalled after being wrongly labelled as Aspirin

The Pharmacist

Almost 120,000 packs of Boots Paracetamol have been recalled because of a packaging error where they are incorrectly labelled as Aspirin on the foil blister. The Medicines and Healthcare products Regulatory Agency (MHRA) has today issued a recall alert for a specific batch of Boots Paracetamol 500mg (16s) and has advised the public to stop […] The post Boots Paracetamol batch recalled after being wrongly labelled as Aspirin appeared first on The Pharmacist.

article thumbnail

The Comprehensive Science and Art of Pharmaceutical Drug Naming

Drug Patent Watch

The Secret Language of Medicines: Uncovering the Science Behind Pharmaceutical Drug Names As professionals in the healthcare and pharmaceutical industries, we've all seen them - the long, complex names of medications that seem to defy pronunciation. But have you ever stopped to think about the process behind creating these names? It's a fascinating world of science and art that's crucial to ensuring patient safety and efficacy.

article thumbnail

VeGen Labs secures BIRAC funding to advance KRAS Inhibitor

Express Pharma

VeGen Labs, an emerging biotechnology startup in India, has been awarded 3,765 crores of Royalty-based financial support from the Biotechnology Industry Research Assistance Council (BIRAC), a Government of India enterprise set up by the Department of Biotechnology. This funding will support Investigational New Drug (IND)-enabling toxicology studies for IND126, a novel KRAS inhibitor, marking a significant step toward clinical development for Non-Small Cell Lung Cancer (NSCLC) patients in India.

102
102
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

As tariffs loom over pharma manufacturing, a reshoring effort is underway — but not without challenges

PharmaVoice

Experts say cost and other barriers present challenges to returning to U.S. shores.

238
238
article thumbnail

CHMP meeting highlights – February 2025

European Pharmaceutical Review

Four medicines were recommended for approval at the EMAs human medicines committee (CHMP)s February 2025 meeting. A marketing authorisation for Deqsiga (human normal immunoglobulin) was granted as a replacement therapy for primary or secondary immunodeficiencies and immunomodulation in individuals with certain autoimmune conditions. The group recommended authorisation of two medicines for oncology indications.

article thumbnail

Opinion: ‘Post-vaccination syndrome’: a dubious diagnosis that could do harm

STAT

Recently, the notorious conspiracy theory peddler Alex Jones shared an “Infowars” video on X lambasting the “horrific side effects” of Covid vaccines: “Yale scientists link COVID vaccines to alarming new syndrome causing distinct biological changes to the body,” his post read. News of the new study spread like wildfire throughout right-wing anti-vaccine circles, amplified by the likes of Alex Berenson , Elon Musk , and Joe Rogan , who touted the study as

Vaccines 362
article thumbnail

NICE approves daily pill for endometriosis where other treatments have failed

The Pharmacist

A daily pill has been approved by NICE for treating some women with endometriosis after initially being rejected. It is estimated around 1,000 patients a year will be able to access the treatment called relugolixestradiolnorethisterone (also known as relugolix combination therapy or Ryeqo). The turnaround from NICE came after the company provided new evidence on […] The post NICE approves daily pill for endometriosis where other treatments have failed appeared first on The Pharmacist.

95
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.